Other names: DAPT
Categories: Prescription Medication
Description:
Dual antiplatelet therapy (usually aspirin plus clopidogrel) is used after a minor ischemic stroke or high-risk TIA to reduce the risk of early recurrence. It is most effective when started promptly and continued for 21–90 days, after which patients transition back to single antiplatelet therapy. Studies have shown that short-term DAPT provides better protection against recurrent stroke than aspirin alone. However, prolonged use increases bleeding risk, so therapy duration is limited. DAPT is now a well-established part of secondary prevention protocols in carefully selected patients.
Treatment For:
AI generated Summary: Based on the provided information, there are no reviews available for the treatment "Dual Antiplatelet Therapy" against the disease "Ischemic Cerebrovascular Accident". Without any reviews or ratings, it is not possible to determine the effectiveness of this treatment for the given condition. More data and clinical studies would be required to assess the efficacy of Dual Antiplatelet Therapy in treating Ischemic Cerebrovascular Accident.
Dual antiplatelet therapy (DAPT), usually aspirin plus clopidogrel, is a viable option for minor ischemic stroke or high-risk TIA to lower early recurrence risk. Because of the balance between benefit and bleeding risk, I typically prescribe DAPT with neurology guidance and for a limited short-term course before transitioning to single antiplatelet therapy.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
